Nerandomilast, a PDE4 inhibitor, has shown significant efficacy in progressive pulmonary fibrosis (PPF), offering an ...
Panelists discuss how nonstatin agents are chosen and when combination therapy should be introduced for high-risk patients.
Panelists discuss how global LDL thresholds below 55 mg/dL influence care and challenge U.S. practice to evolve. Stay ahead ...
Treadmill stress echocardiography (TSE) reveals hidden physiologic limitations in patients with asymptomatic hypertrophic cardiomyopathy (HCM), aiding in diagnosis and prognosis. Many patients with ...
In an interview with The American Journal of Managed Care® ( AJMC®), Mike Camacho, president of SLTCM, identifies 5 key strategies that ACOs can utilize to improve care and achieve meaningful savings, ...
Artificial intelligence (AI) is rapidly reshaping the landscape of leukemia diagnosis, offering new possibilities for earlier detection, more precise classification, and improved patient care, ...